We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current 0JDI market cap is 6.2B. The company's latest EPS is USD -2.5530 and P/E is -16.63.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.12B | 729.26M | 810.46M | 587.37M | 787.65M |
| Operating Income | 365.88M | -172.08M | -30.19M | -410.19M | -353.73M |
| Net Income | 294.15M | -451.29M | -28.6M | -269.72M | -366.29M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.23B | 2.39B | 2.61B | 2.53B | 2.99B |
| Total Liabilities | 1.55B | 1.55B | 1.84B | 1.96B | 2.6B |
| Total Equity | 1.68B | 843.35M | 771.74M | 572.89M | 386.69M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 345.72M | 35.89M | 30.8M | -274.37M | -307.51M |
| Investing | -41.27M | 274.48M | 194.91M | -262.64M | -214.13M |
| Financing | 100.02M | -596.61M | 245.93M | -55.3M | 644.08M |
| Market Cap | 6.2B |
| Price to Earnings Ratio | -16.63 |
| Price to Sales Ratio | 7.73 |
| Price to Cash Ratio | 15.25 |
| Price to Book Ratio | 15.75 |
| Dividend Yield | - |
| Shares Outstanding | 143.47M |
| Average Volume (1 week) | 37 |
| Average Volume (1 Month) | 61 |
| 52 Week Change | 0.00% |
| 52 Week High | 43.23 |
| 52 Week Low | 43.23 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Ionis Pharmaceuticals Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.isispharm.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
